Company Profiles

driven by the PitchBook Platform

Akinion Pharmaceuticals

Description

Operator of a drug development company focusing on the treatment of acute myeloid leukemia (AML). The company develops kinase receptor inhibitors for the treatment of acute myeloid leukemia.

2009

Founded

PRIVATE

Status

11-50

Employees

Early Stage VC

Latest Deal Type

3

Investors

Description

Operator of a drug development company focusing on the treatment of acute myeloid leukemia (AML). The company develops kinase receptor inhibitors for the treatment of acute myeloid leukemia.

Website:

www.akinion.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Drug Discovery

Other Industries

Pharmaceuticals

Primary Office

Karolinska Institutet Science Park Nobels väg 3 171 65 SolnaSweden +46 (0)8 524 869 65
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Akinion Pharmaceuticals's full profile, request a free trial.

Akinion Pharmaceuticals Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Akinion Pharmaceuticals Investors (3)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
b-to-v PartnersVenture CapitalMinority000 0000000 0000
Karolinska DevelopmentVenture CapitalMinority000 0000000 0000
Rosetta Capital(London)Venture CapitalMinority000 0000000 0000
b-to-v Partners Venture Capital
Karolinska Development Venture Capital
Rosetta Capital(London) Venture Capital

Akinion Pharmaceuticals Executive Team (7)

NameTitleBoard
Seat
Contact
Info
Vendela Parrow MDCo-Chief Scientific Officer & Co-Chief Executive Officer
Richard Jones Ph.DCo-Chief Executive Officer & Board Member
Lars Abrahmsén Ph.DVice President of Preclinical Development & Chief Scientific Officer
Kristina CarlssonDirector, Regulatory Affairs
Mikael von Euler Ph.DChief Medical Officer & Vice President, Clinical Development
Vendela Parrow MD Co-Chief Scientific Officer & Co-Chief Executive Officer
Richard Jones Ph.D Co-Chief Executive Officer & Board Member
Lars Abrahmsén Ph.D Vice President of Preclinical Development & Chief Scientific Officer
Kristina Carlsson Director, Regulatory Affairs
Mikael von Euler Ph.D Chief Medical Officer & Vice President, Clinical Development

Akinion Pharmaceuticals Board Members (5)

NameRepresentingRoleSinceContact
Info
Graham Fagg Ph.DRosetta Capital(London)Partner000 0000
Michael MooreAkinion PharmaceuticalsChairman000 0000
Richard Jones Ph.DAkinion PharmaceuticalsCo-Chief Executive Officer & Board Member000 0000
Stefan Fraenkel Ph.DSelfBoard Member000 0000
Viktor DrvotaAkinion PharmaceuticalsBoard Member000 0000
Graham Fagg Ph.D Partner Rosetta Capital(London)
Michael Moore Chairman Akinion Pharmaceuticals
Richard Jones Ph.D Co-Chief Executive Officer & Board Member Akinion Pharmaceuticals
Stefan Fraenkel Ph.D Board Member Self
Viktor Drvota Board Member Akinion Pharmaceuticals
Request full access to PitchBook